List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 145 studies with search of: "Diphtheria"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Completed Canadian Manufactured Tetanus and Diphtheria Toxoids Adsorbed (Td) Vaccine Compared With U.S. Manufactured Td
Conditions: Diphtheria;   Tetanus
Interventions: Biological: TENIVAC™;   Biological: DECAVAC®
2 Enrolling by invitation An Immunogenicity and Safety Study of Tetanus, Diphtheria and Acellular Pertussis Vaccine Booster
Conditions: Tetanus;   Diphtheria;   Pertussis
Interventions: Biological: Td5ap;   Biological: Td1aP
3 Completed Immunogenicity and Safety Study of a Booster Dose (5th) of Diphteria-Tetanus-Pertussis-Polio Vaccine
Conditions: Diphtheria;   Tetanus;   Pertussis;   Polio
Intervention: Drug: Boostrix polio
4 Completed Study of Menactra® in US Adolescents When Administered Concomitantly With Tdap Vaccine
Conditions: Meningitis;   Meningococcemia;   Pertussis;   Tetanus;   Diphtheria
Interventions: Biological: T dap + Meningococcal Polysaccharide Diphtheria Toxoid Conj.;   Biological: Tdap + Meningococcal Polysaccharide Diphtheria Toxoid Conj.;   Biological: Meningococcal Polysaccharide Diphtheria Toxoid Conj. + T dap
5 Completed REVAXIS® Versus DT Polio® as a Second Booster in 6 Year-Old Children
Conditions: Diphtheria;   Tetanus;   Poliomyelitis
Interventions: Biological: REVAXIS®;   Biological: DT-Polio®
6 Enrolling by invitation Immune Responses in Adults to Revaccination With ADACEL® 10 Years After a Previous Dose
Conditions: Pertussis;   Tetanus;   Diphtheria
Interventions: Biological: Tetanus, Reduced Diphtheria Toxoid and Acellular Pertussis (ADACEL®);   Biological: Tetanus, Reduced Diphtheria Toxoid and Acellular Pertussis (ADACEL®)
7 Recruiting Database Surveillance Safety Study of PENTACEL® Vaccine
Conditions: Diphtheria;   Tetanus;   Pertussis;   Haemophilus Influenzae
Interventions: Biological: DTaP-IPV/Hib;   Biological: Other DTap Vaccines
8 Active, not recruiting Phase IV Interchangeability Study of a Liquid Pentavalent Combination Vaccine
Conditions: Diphtheria;   Tetanus;   Pertussis;   Hepatitis B;   Haemophilus Influenzae Type B
Interventions: Biological: Shan 5;   Biological: Easy Five
9 Completed Study of DAPTACEL® Administered as a 5th Dose in 4 to 6-Year-Old Children Previously Immunized With PENTACEL™
Conditions: Diphtheria;   Tetanus;   Pertussis;   Polio;   Haemophilus Influenzae Type B
Intervention: Biological: Diphtheria and Tetanus Toxoids and Acellular Pertussis (DAPTACEL®)
10 Completed Concomitant Use of Gardasil (V501) (Human Papillomavirus [Types 6, 11, 16, 18] Recombinant Vaccine) With Combined Diphtheria, Tetanus, Pertussis Vaccine and Meningococcal Conjugate Vaccine in Adolescents
Conditions: Neoplasms, Glandular and Epithelial;   Diphtheria;   Tetanus;   Whooping Cough;   Meningitis
Interventions: Biological: Comparator: Quadrivalent HPV vaccine;   Biological: Comparator: Menactra™ (Concomitant);   Biological: Comparator: Adacel™ (Concomitant);   Biological: Comparator: Menactra™ (Non-concomitant);   Biological: Comparator: Adacel™
11 Completed Concomitant Use of Gardasil (V501, Human Papillomavirus [Types 6, 11, 16, 18] Recombinant Vaccine) With Combined Diptheria, Tetanus, Pertussis and Poliomyelitis Vaccine in Adolescents
Conditions: Neoplasms, Glandular and Epithelial;   Diphtheria;   Tetanus;   Whooping Cough;   Poliomyelitis
Interventions: Biological: Comparator: Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant (qHPV) Vaccine from Current Manufacturing Facility (CMF);   Biological: Comparator: Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant (qHPV) Vaccine from Future Manufacturing Facility (FMF);   Biological: Comparator: REPEVAX™ (Concomitant);   Biological: Comparator: REPEVAX™ (Non-Concomitant)
12 Completed Post-Marketing Safety Study of GSK Biologicals' Boostrix® Vaccine.
Condition: Prophylaxis Against Diphtheria, Tetanus, and Pertussis
Interventions: Biological: Td (Tetanus diphtheria) vaccine;   Biological: Boostrix®
13 Enrolling by invitation Study of the DTacP-IPV-HepB-PRP-T Combined Vaccine Following a Primary Series of DTacP IPV-HepB-PRP-T or Infanrix Hexa™
Conditions: Diphtheria;   Tetanus;   Pertussis;   Hepatitis B;   Poliomyelitis;   Haemophilus Influenzae Type B
Intervention: Biological: DTaP-IPV-HB-PRP~T vaccine
14 Active, not recruiting Study of Immunogenicity and Safety of a Booster Dose of DTaP-IPV-HB-PRP~T Combined Vaccine in Healthy Turkish Infants
Conditions: Diphtheria;   Polio;   Pertussis;   Hepatitis B
Intervention: Biological: DTaP-IPV-HB-PRP~T vaccine
15 Active, not recruiting Immunogenicity Study of Antibody Persistence and Booster Effect of DTaP HB PRP~T Combined Vaccine in Filipino Infants
Conditions: Diphtheria;   Tetanus;   Pertussis;   Hepatitis B;   Heamophilus Influenza
Interventions: Biological: DTaP HB PRP~T Combined Vaccine;   Biological: DTaP-HB-PRP~T vaccine
16 Active, not recruiting Safety of DTaP-IPV-HB-PRP~T Combined Vaccine Compared to Tritanrix-HepB/Hib™ and OPV Given at Age 2, 4, and 6 Months.
Conditions: Diphtheria;   Tetanus;   Pertussis;   Haemophilus Influenzae Type B;   Hepatitis B
Interventions: Biological: DTaP-IPV-HB-PRP~T;   Biological: Tritanrix-HepB/Hib
17 Active, not recruiting Immunogenicity and Safety of Adacel Polio Vaccine
Conditions: Diphtheria;   Tetanus;   Pertussis;   Poliomyelitis
Intervention: Biological: TdcP-IPV vaccine
18 Completed Study of DTaP-IPV-Hep B-PRP~T Combined Vaccine Compared With PENTAXIM™ and ENGERIX B® PEDIATRICO in Argentinean Infants
Conditions: Diphtheria;   Tetanus;   Pertussis;   Haemophilus Influenzae Type B;   Poliomyelitis
Interventions: Biological: DTaP-IPV-HB-PRP~T;   Biological: DTaP-IPV//PRP~T combined vaccine & Recombinant hep B vaccine
19 Active, not recruiting Safety and Immunogenicity Study of a Liquid Pentavalent Combination Vaccine
Conditions: Diphtheria;   Tetanus;   Pertussis;   Hepatitis B;   Haemophilus Influenzae Type B
Intervention: Biological: Shan5
20 Completed Immunogenicity Study of Antibody Persistence and Booster Effect of PENTAXIM™ at 18 Months in Healthy Argentinean Infants
Conditions: Diphtheria;   Tetanus;   Pertussis;   Poliomyelitis;   Hepatitis B
Interventions: Biological: DTaP-IPV-HB-PRP~T combined vaccine;   Biological: DTaP-IPV//PRP~T combined vaccine

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services